Display options
Share it on

Nanoscale Res Lett. 2013 May 16;8(1):236. doi: 10.1186/1556-276X-8-236.

Studies of single-walled carbon nanotubes-induced hepatotoxicity by NMR-based metabonomics of rat blood plasma and liver extracts.

Nanoscale research letters

Bencheng Lin, Huashan Zhang, Zhiqing Lin, Yanjun Fang, Lei Tian, Honglian Yang, Jun Yan, Huanliang Liu, Wei Zhang, Zhuge Xi

Affiliations

  1. Institute of health and Environmental Medicine, Key Laboratory of Risk Assessment and Control Technology for Environment and Food Safety, No,1, Dali Road, Tianjin 300050, China. [email protected].

PMID: 23680025 PMCID: PMC3664573 DOI: 10.1186/1556-276X-8-236

Abstract

The toxicological effects of single-walled carbon nanotubes (SWCNTs) were investigated after intratracheal instillation in male Wistar rats over a 15-day period using metabonomic analysis of 1H (nuclear magnetic resonance) NMR spectra of blood plasma and liver tissue extracts. Concurrent liver histopathology examinations and plasma clinical chemistry analyses were also performed. Significant changes were observed in clinical chemistry features, including alkaline phosphatase, total protein, and total cholesterol, and in liver pathology, suggesting that SWCNTs clearly have hepatotoxicity in the rat. 1H NMR spectra and pattern recognition analyses from nanomaterial-treated rats showed remarkable differences in the excretion of lactate, trimethylamine oxide, bilineurin, phosphocholine, amylaceum, and glycogen. Indications of amino acid metabolism impairment were supported by increased lactate concentrations and decreased alanine concentrations in plasma. The rise in plasma and liver tissue extract concentrations of choline and phosphocholine, together with decreased lipids and lipoproteins, after SWCNTs treatment indicated a disruption of membrane fluidity caused by lipid peroxidation. Energy, amino acid, and fat metabolism appeared to be affected by SWCNTs exposure. Clinical chemistry and metabonomic approaches clearly indicated liver injury, which might have been associated with an indirect mechanism involving nanomaterial-induced oxidative stress.

References

  1. Neoplasia. 2009 Mar;11(3):269-76, 4p following 269 - PubMed
  2. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):314-25 - PubMed
  3. Expert Rev Proteomics. 2007 Jun;4(3):389-400 - PubMed
  4. Food Chem Toxicol. 2010 Jun;48(6):1521-7 - PubMed
  5. J Appl Toxicol. 2013 Sep;33(9):933-9 - PubMed
  6. Biomarkers. 2004 Mar-Apr;9(2):116-38 - PubMed
  7. Diabetes. 2009 Nov;58(11):2429-43 - PubMed
  8. Pharmacol Ther. 2009 Feb;121(2):192-204 - PubMed
  9. Toxicol Appl Pharmacol. 2005 Sep 15;207(3):221-31 - PubMed
  10. Toxicology. 2009 Mar 29;257(3):161-71 - PubMed
  11. Toxicol In Vitro. 2011 Dec;25(8):1883-8 - PubMed
  12. NMR Biomed. 2005 May;18(3):143-62 - PubMed
  13. Nanomedicine. 2010 Jun;6(3):427-41 - PubMed
  14. Chem Res Toxicol. 2005 Apr;18(4):639-54 - PubMed
  15. Toxicol Appl Pharmacol. 2006 Aug 15;215(1):71-82 - PubMed
  16. Toxicol Appl Pharmacol. 2010 Nov 1;248(3):178-84 - PubMed
  17. Chem Res Toxicol. 2000 Jun;13(6):471-8 - PubMed
  18. Biomarkers. 2004 Mar-Apr;9(2):156-79 - PubMed
  19. Xenobiotica. 2005 Aug;35(8):839-52 - PubMed
  20. Regul Toxicol Pharmacol. 2011 Nov;61(2):192-8 - PubMed
  21. Expert Opin Drug Deliv. 2009 May;6(5):517-30 - PubMed
  22. PLoS One. 2011;6(10):e25892 - PubMed
  23. J Pharm Biomed Anal. 2004 Apr 1;35(1):93-105 - PubMed
  24. Wei Sheng Yan Jiu. 2008 Nov;37(6):651-3 - PubMed
  25. Toxicol Appl Pharmacol. 2008 Oct 15;232(2):292-301 - PubMed
  26. J Appl Toxicol. 2011 Jan;31(1):75-83 - PubMed

Publication Types